Feasibility study of FDG PET as an indicator of early response to aromatase inhibitors and trastuzumab in a heterogeneous group of breast cancer patients.
EJNMMI Res., 2(1):34 (2012)
Immune-based therapies for sarcoma.
Sarcoma., 2011:438940 (2011)
(18)F-FDG PET in sarcoma treatment response imaging.
Am J Nucl Med Mol Imaging., 1(1):47-53 (2011)